AxoGen Inc

AXGN exhibited a terminal Capitulation (Final Flush) bar on extreme volume, signaling forced liquidation is ending and setting up a potential reflex rally within the long-term uptrend. Medium-term directional asymmetry shifts bullish given the terminal pattern, but price remains extended below the 9- and 21-day EMAs without evidence of stabilization. Execution should be deferred (Stalk) and focused on pullback absorption or early signs of a hold near intermediate moving averages before buying.

• ↑Q2 revenue +23.1% YoY to $69.7M, driven by surgeon engagement
• ↑Breast segment revenue +50% YoY, boosting overall growth
• ↓Q2 gross margin fell to 72.7% from 74.2% due to costlier breast procedures